Gene · 389421
Papers2,505
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,505
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Properties and fate of human mesenchymal stem cells upon miRNA let-7f-promoted recruitment to atherosclerotic plaques. | Cardiovasc Res | 2023 | 35238350 | PubTator, text mining | PubMed |
| The significance of the crosstalk between ubiquitination or deubiquitination and ncRNAs in non-small cell lung cancer. | Front Oncol | 2022 | 36727069 | PubTator, text mining | PubMed |
| Construction and validation of a novel ferroptosis-related signature for evaluating prognosis and immune microenvironment in ovarian cancer. | Front Genet | 2022 | 36685851 | PubTator, text mining | PubMed |
| MicroRNAs as Biomarkers for Coronary Artery Disease Related to Type 2 Diabetes Mellitus-From Pathogenesis to Potential Clinical Application. | Int J Mol Sci | 2022 | 36614057 | PubTator, text mining | PubMed |
| Association between LIN28B gene polymorphisms and Wilms' tumor susceptibility. | Biomark Med | 2022 | 36606447 | PubTator, text mining | PubMed |
| Understanding the Dual Roles of CircHIPK3 in Tumorigenesis and Tumor Progression. | J Cancer | 2022 | 36606192 | PubTator, text mining | PubMed |
| Pharmacological inhibition of Lin28 promotes ketogenesis and restores lipid homeostasis in models of non-alcoholic fatty liver disease. | Nat Commun | 2022 | 36572670 | PubTator, text mining | PubMed |
| Evodiamine exerts inhibitory roles in non‑small cell lung cancer cell A549 and its sub‑population of stem‑like cells. | Exp Ther Med | 2022 | 36561974 | PubTator, text mining | PubMed |
| Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis. | Front Endocrinol (Lausanne) | 2022 | 36545327 | PubTator, text mining | PubMed |
| m5C regulator-mediated modification patterns and tumor microenvironment infiltration characterization in colorectal cancer: One step closer to precision medicine. | Front Immunol | 2022 | 36532062 | PubTator, text mining | PubMed |
| A review of the genetics and epigenetics of central precocious puberty. | Front Endocrinol (Lausanne) | 2022 | 36531492 | PubTator, text mining | PubMed |
| The progress and challenges of circRNA for diabetic foot ulcers: A mini-review. | Front Endocrinol (Lausanne) | 2022 | 36531481 | PubTator, text mining | PubMed |
| LINC00858 stabilizes RAN expression and promotes metastasis of gastric cancer. | Biol Direct | 2022 | 36528654 | PubTator, text mining | PubMed |
| Occurrence and role of lung megakaryocytes in infection and inflammation. | Front Immunol | 2022 | 36524131 | PubTator, text mining | PubMed |
| Immunohistochemical expression of Drosha is reduced in eutopic and ectopic endometrium of women with adenomyosis. | Braz J Med Biol Res | 2022 | 36515351 | PubTator, text mining | PubMed |
| PLK1-ELAVL1/HuR-miR-122 signaling facilitates hepatitis C virus proliferation. | Proc Natl Acad Sci U S A | 2022 | 36512502 | PubTator, text mining | PubMed |
| MicroRNA29B induces fetal hemoglobin via inhibition of the HBG repressor protein MYB in vitro and in humanized sickle cell mice. | Front Med (Lausanne) | 2022 | 36507536 | PubTator, text mining | PubMed |
| Expression patterns of platinum resistance-related genes in lung adenocarcinoma and related clinical value models. | Front Genet | 2022 | 36506331 | PubTator, text mining | PubMed |
| The importance of fusion protein activity in Ewing sarcoma and the cell intrinsic and extrinsic factors that regulate it: A review. | Front Oncol | 2022 | 36505823 | PubTator, text mining | PubMed |
| MYCN mRNA degradation and cancer suppression by a selective small-molecule inhibitor in MYCN-amplified neuroblastoma. | Front Oncol | 2022 | 36505784 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389421/papers?page=19